2C-T-2: Difference between revisions
>Kenan m Remove affinities |
>Unity Moved part of introduction to history and culture section. Grammatics. Cleaned up legal section. |
||
Line 7: | Line 7: | ||
2C-T-2 was first synthesized and tested for activity in humans by [[Alexander Shulgin]] in 1981<ref>Shulgin, Alexander. "Pharmacology Lab Notes #4". Lafayette, CA. (1981-1982). p474 (Erowid.org) | https://erowid.org/library/books_online/shulgin_labbooks/shulgin_pharmacology_notebook4_searchable.pdf</ref> and described in his 1991 book [[PiHKAL]] ("Phenethylamines I Have Known and Loved").<ref name="pihkal2CT2">Shulgin, A., & Shulgin, A. (1991). | 2C-T-2 was first synthesized and tested for activity in humans by [[Alexander Shulgin]] in 1981<ref>Shulgin, Alexander. "Pharmacology Lab Notes #4". Lafayette, CA. (1981-1982). p474 (Erowid.org) | https://erowid.org/library/books_online/shulgin_labbooks/shulgin_pharmacology_notebook4_searchable.pdf</ref> and described in his 1991 book [[PiHKAL]] ("Phenethylamines I Have Known and Loved").<ref name="pihkal2CT2">Shulgin, A., & Shulgin, A. (1991). | ||
[http://isomerdesign.com/PiHKAL/read.php?id=33 IsomerDesign: "PiHKAL" - #33 - 2C-I]. Retrieved Jan 22, 2018.</ref> It is a member of the so-called "magical half-dozen" which refers to Shulgin's self-rated most important [[phenethylamine]]-derived compounds, all of which except [[mescaline]] he developed and synthesized himself. They are found within the first book of [[PiHKAL]], and are as follows: [[mescaline]], [[DOM]], [[2C-B]], 2C-E, [[2C-T-2]] and [[2C-T-7]].<ref name="pihkalweb">Shulgin, A., & Shulgin, A. (1991). [https://www.erowid.org/library/books_online/pihkal/pihkal.shtml Erowid Online Books: "PIHKAL" - The Chemical Story]. Retrieved April 14, 2017.</ref> | [http://isomerdesign.com/PiHKAL/read.php?id=33 IsomerDesign: "PiHKAL" - #33 - 2C-I]. Retrieved Jan 22, 2018.</ref> It is a member of the so-called "magical half-dozen" which refers to Shulgin's self-rated most important [[phenethylamine]]-derived compounds, all of which except [[mescaline]] he developed and synthesized himself. They are found within the first book of [[PiHKAL]], and are as follows: [[mescaline]], [[DOM]], [[2C-B]], 2C-E, [[2C-T-2]] and [[2C-T-7]].<ref name="pihkalweb">Shulgin, A., & Shulgin, A. (1991). [https://www.erowid.org/library/books_online/pihkal/pihkal.shtml Erowid Online Books: "PIHKAL" - The Chemical Story]. Retrieved April 14, 2017.</ref> | ||
Anecdotal reports generally characterize 2C-T-2 as a highly dose sensitive psychedelic known for its open headspace and unpredictable [[body load]]. | Anecdotal reports generally characterize 2C-T-2 as a highly dose sensitive psychedelic known for its open headspace and unpredictable [[body load]]. | ||
Very little data exists about the pharmacological properties, metabolism, and toxicity of 2C-T-2, and it has little history of human usage. Many reports also indicate that its physical effects may be too severe for those who are not already experienced with [[psychedelics]] or suffer from pre-existing physical conditions. It is highly advised to approach this [[hallucinogenic]] substance with the proper amount of precaution and [[harm reduction practices]] if | Very little data exists about the pharmacological properties, metabolism, and toxicity of 2C-T-2, and it has little history of human usage. Many reports also indicate that its physical effects may be too severe for those who are not already experienced with [[psychedelics]] or suffer from pre-existing physical conditions. It is highly advised to approach this [[hallucinogenic]] substance with the proper amount of precaution and [[harm reduction practices]] if using it. | ||
==History and culture== | ==History and culture== | ||
{{historyStub}} | {{historyStub}} | ||
Following the initial positive results found by Shulgin's research group, a more formal study was carried out by psychedelic psychotherapy pioneer Myron J. Stolaroff who was interested in evaluating the potential use of 2C-T-2 in psychotherapy.<ref>Stolaroff, MJ; Wells, C. Preliminary results with new psychoactive agents 2C-T-2 and 2C-T-7. In Jahrbuch für Ethnomedizin und Bewußtseinsforschung (Yearbook of Ethnomedicine and the Study of Consciousness); Rätsch, C; Baker, J, Eds., 1993; Vol. 2, pp 99–117. (MAPS.org) | http://www.maps.org/images/pdf/1993_stolaroff_1.pdf</ref> Based on the experiences of forty participants in the study who took 2C-T-2, Stolaroff compared the effects favorably to [[MDMA]], describing it as more emotionally opening and permitting a wider exploration of feelings and thoughts. | |||
==Chemistry== | ==Chemistry== | ||
Line 120: | Line 119: | ||
It is strongly recommended that one use [[responsible drug use|harm reduction practices]] when using this substance. | It is strongly recommended that one use [[responsible drug use|harm reduction practices]] when using this substance. | ||
=== | ===Dependence and abuse potential=== | ||
2C-T-2 is [[Addiction potential::not habit-forming]] and the desire to use it can actually decrease with use. It is most often self-regulating. | 2C-T-2 is [[Addiction potential::not habit-forming]] and the desire to use it can actually decrease with use. It is most often self-regulating. | ||
Line 161: | Line 160: | ||
|} | |} | ||
== | ==Legal status== | ||
*'''Australia:''' 2C-T-2 is illegal in Australia as of 2005.{{citation needed}} | |||
*'''Austria:''' 2C-T-2 is illegal to possess, produce and sell under the SMG (Suchtmittelgesetz Österreich).{{citation needed}} | |||
*'''Australia:''' 2C-T-2 is illegal in Australia as of 2005. | *'''Belgium:''' 2C-T-2 was added to the list of illegal psychotropic substances on Nov 8, 2004.{{citation needed}} | ||
*'''Austria:''' 2C-T-2 is illegal to possess, produce and sell under the SMG | *'''Brazil:''' 2C-T-2 is illegal to possess, produce and sell as it is listed on Portaria SVS/MS nº 344.<ref>http://portal.anvisa.gov.br/documents/10181/3115436/%281%29RDC_130_2016_.pdf/fc7ea407-3ff5-4fc1-bcfe-2f37504d28b7</ref> | ||
*'''Belgium:''' 2C-T-2 was added to the list of illegal psychotropic substances on Nov 8, 2004. | *'''Canada:''' 2C-T-2 would be considered Schedule III as it is a derivative of 2,5-dimethoxyphenethylamine.<ref>Controlled Drugs and Substances Act (S.C. 1996, c. 19) |http://laws-lois.justice.gc.ca/eng/acts/C-38.8/page-12.html#h-28</ref> | ||
*'''Brazil''' - | *'''China:''' As of October 2015, 2C-T-2 is a controlled substance in China.<ref>{{cite web | url=http://www.sfda.gov.cn/WS01/CL0056/130753.html | title=关于印发《非药用类麻醉药品和精神药品列管办法》的通知 | publisher=China Food and Drug Administration | date=27 September 2015 | language=Chinese | accessdate=1 October 2015}}</ref> | ||
*'''Denmark:''' 2C-T-2 was added to category B of the controlled substances list on August 23, 2003.<ref>https://www.riigiteataja.ee/aktilisa/1090/2201/1004/109022011004Lisa1.pdf</ref> | *'''Denmark:''' 2C-T-2 was added to category B of the controlled substances list on August 23, 2003.<ref>https://www.riigiteataja.ee/aktilisa/1090/2201/1004/109022011004Lisa1.pdf</ref> | ||
*'''European Union:''' EU Council published an order on Dec 6, 2003, asking all member states to control 2C-I, 2C-T-2, 2C-T-7, and TMA-2. | *'''European Union:''' The EU Council published an order on Dec 6, 2003, asking all member states to control 2C-I, 2C-T-2, 2C-T-7, and TMA-2.{{citation needed}} | ||
*'''Germany''' - | *'''Germany:''' 2C-T-2 is illegal to possess, produce and sell.<ref>BtMG Anlage I | https://www.gesetze-im-internet.de/btmg_1981/anlage_i.html</ref> | ||
*'''Italy:''' 2C-T-2 was added to the "Tabella 1" in a Jan 11, 2005 Ministry of Health statement. | *'''Italy:''' 2C-T-2 was added to the "Tabella 1" in a Jan 11, 2005 Ministry of Health statement.{{citation needed}} | ||
*'''Japan:''' 2C-T-2 is controlled as a "Designated Substance" (Shitei-Yakubutsu) by the Pharmaceutical Affairs Law, making it illegal to possess or sell | *'''Japan:''' 2C-T-2 is controlled as a "Designated Substance" (Shitei-Yakubutsu) by the Pharmaceutical Affairs Law, making it illegal to possess or sell.{{citation needed}} | ||
*'''Latvia:''' 2C-T-2 is a Schedule I controlled substance.<ref>Noteikumi par Latvijā kontrolējamajām narkotiskajām vielām, psihotropajām vielām un prekursoriem (2,5-Dimetoksifeniletānamīni) | http://likumi.lv/doc.php?id=121086</ref> | *'''Latvia:''' 2C-T-2 is a Schedule I controlled substance.<ref>Noteikumi par Latvijā kontrolējamajām narkotiskajām vielām, psihotropajām vielām un prekursoriem (2,5-Dimetoksifeniletānamīni) | http://likumi.lv/doc.php?id=121086</ref> | ||
*'''Netherlands:''' | *'''Netherlands:''' 2C-T-2 was classified as an unregistered pharmaceutical as of April 12, 1999. Unlicensed manufacture, sale, import, trade and possession of this substance can be prosecuted.{{citation needed}} | ||
*'''Switzerland:''' | *'''Switzerland:''' 2C-T-2 is illegal to possess, produce and sell.<ref>http://web.archive.org/web/20170329020935/https://www.admin.ch/opc/de/classified-compilation/20101220/index.html</ref> | ||
*''' | *'''United Kingdom:''' 2C-T-2 is a Class A drug in the United Kingdom as a result of the phenethylamine catch-all clause.<ref>United Kingdom. (1977). Misuse of Drugs Act 1971 (S.I. 1977/1243). London: The Stationery Office Limited. Retrieved July 5, 2017, from http://www.legislation.gov.uk/uksi/1977/1243/made</ref> | ||
*''' | *'''United States:''' 2C-T-2 is a Schedule 1 drug in the U.S., making it illegal to possess, manufacture, or import.{{citation needed}} | ||
==See also== | ==See also== | ||
Line 191: | Line 190: | ||
*[https://erowid.org/chemicals/2ct2/2ct2.shtml 2C-T-2 (Erowid Vault)] | *[https://erowid.org/chemicals/2ct2/2ct2.shtml 2C-T-2 (Erowid Vault)] | ||
*[https://isomerdesign.com/PiHKAL/read.php?domain=pk&id=40 2C-T-2 (PiHKAL / Isomer Design)] | *[https://isomerdesign.com/PiHKAL/read.php?domain=pk&id=40 2C-T-2 (PiHKAL / Isomer Design)] | ||
===Discussion=== | |||
*[http://www.bluelight.org/vb/threads/95005-The-Big-amp-Dandy-2C-T-2-Thread 2C-T-2 (Bluelight)] | *[http://www.bluelight.org/vb/threads/95005-The-Big-amp-Dandy-2C-T-2-Thread 2C-T-2 (Bluelight)] | ||